Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine. In a commentary published in the journal Diabetes Research and Clinical Practice, Miller School of Medicine professor and endocrinologist Gianluca Iacobellis, M.D., Ph.D., suggests the DPP4 enzyme presents an interesting target for further research, and DPP4 inhibitors could help some COVID-19 patients.
- Faced with shortages, researchers combine heat and humidity to disinfect N95 masks
- 160 genes linked to brain shrinkage in study of 45,000 adults
- Ascorbic acid-mediated reactions in organic synthesis
- COVID-19 news from Annals of Internal Medicine
- Coldest Northern Hemisphere temperature, first recorded by UW, officially confirmed